Disk-diffusion tests performed according to the Clinical and Laboratory Standards Institute interpretive standards for Burkholderia cepacia (5) revealed that BF370 was sensitive to ceftazidime, meropenem, and trimethoprim/sulfamethoxazole. Additional characterization of BF370 with multilocus sequence typing (6) revealed a novel sequence type, 868. Novel alleles were found for 7 loci: atpD (allele 347), gltB (allele 409), gyrB (allele 609), recA (allele 367), lepA (allele 418), phaC (allele 319), and trpB (allele 406). Intravenous ampicillin/sulbactam (1.5 g, 3×/d) was administered to the patient from November 29, 2013, through December 13, 2013. No pus was observed at the wound, and the patient was afebrile. He did not report discomfort, and physiotherapy commenced on day 8 after surgery.
Initial identification of the isolate as B. melitensis raised concern for possible laboratory transmission of this pathogen (7) . The possibility of finding brucellae in the synovial tissue was not unexpected because Brucella spp. have been reported to cause joint infections (8) . However, 16S rDNA sequencing confirmed the identity of the isolate as B. fungorum. This different finding suggests that commercial phenotypic identification system could sometimes be unreliable. The isolation of B. fungorum from the synovial tissue of this patient, however, is similar to an earlier case of leg tissue infection in a girl (3). A striking similarity shared between the isolates was their antimicrobial drug susceptibility profiles; each isolate was susceptible to ceftazidime, meropenem, and trimethoprim/sulfamethoxazole. A literature search revealed that B. fungorum had first been recovered from vaginal secretions and cerebrospinal fluid of 2 women (2). However, no clinical information was presented, leading to the absence of clinical descriptions of the infections.
Recently, B. fungorum was detected in a granuloma specimen from a 26-year-old patient (4). The bacteria were suspected to have been transmitted to the patient through a rose thorn puncture. Swelling did not appear until 3 years after the initial puncture, and the patient did not report pain or fever and was otherwise healthy (4) . Although the clinical implication of B. fungorum infection remained unclear, recent cases (3, 4) seem to suggest that the bacteria can induce fever in young children and has a lengthy incubation period before erupting.
We suspect that the patient reported here acquired B. fungorum during his initial injury, perhaps from the environment. The concurrent isolation of M. amorphae, a plant bacterium (9) , is consistent with possible environmental origin of the infection. Our observations and those reported earlier (4) suggest the ability of B. fungorum to act as a slowly replicating opportunistic pathogen associated with tissue injuries. The slow replication rate of B. fungorum presumably mimics the growth characteristic
